Institutions / Propel Bio Management, LLC
Propel Bio Management, LLC
CIK 1969764 · Institution · as of Dec 31, 2025
Portfolio value
$117.12M
Positions
20
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Plains Gp Holdings LPPAGP | $24.35M | 20.8% |
| Achieve Life Sciences, Inc.ACHV | $18.82M | 16.1% |
| Phathom Pharmaceuticals, Inc.PHAT | $12.29M | 10.5% |
| Viridian Therapeutics, Inc. | $8.79M | 7.5% |
| Milestone Pharmaceuticals Inc. | $8.32M | 7.1% |
| Kyverna Therapeutics, Inc.KYTX | $6.27M | 5.4% |
| COMPASS Pathways plcCMPS | $5.95M | 5.1% |
| Inventiva SA - Adr | $4.65M | 4.0% |
| Delcath Systems, Inc. | $4.43M | 3.8% |
| Abeona Therapeutics Inc. | $4.38M | 3.7% |
| Celldex Therapeutics, Inc. | $4.19M | 3.6% |
| Nektar Therapeutics | $3.50M | 3.0% |
| Oculis Holding AG | $3.45M | 2.9% |
| SAB Biotherapeutics, Inc. | $2.44M | 2.1% |
| REGENXBIO Inc. | $1.68M | 1.4% |
| LeonaBio, Inc.LONA | $1.13M | 1.0% |
| LENZ Therapeutics, Inc. | $945.4K | 0.8% |
| Aardvark Therapeutics, Inc.AARD | $609.1K | 0.5% |
| Zevra Therapeutics, Inc. | $570.6K | 0.5% |
| Kalaris Therapeutics, Inc.KLRS | $354.9K | 0.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.